{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:55:46Z","timestamp":1791896146556,"version":"4.3.4"},"reference-count":37,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2014,8,30]],"date-time":"2014-08-30T00:00:00Z","timestamp":1409356800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"Apopharma"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Neurology"],"published-print":{"date-parts":[[2014,10]]},"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>We conducted a 6\u2010month, randomized, double\u2010blind, placebo\u2010controlled study to assess safety, tolerability, and efficacy of deferiprone in Friedreich ataxia (FRDA).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Seventy\u2010two patients were treated with deferiprone 20, 40, or 60mg\/kg\/day or placebo, divided into 2 daily doses. Safety was the primary objective; secondary objectives included standardized neurological assessments (Friedreich Ataxia Rating Scale [FARS], International Cooperative Ataxia Rating Scale [ICARS], 9\u2010Hole Peg Test [9HPT], Timed 25\u2010Foot Walk, Low\u2010Contrast Letter Acuity), general functional status (Activities of Daily Living), and cardiac assessments.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Deferiprone was well tolerated at 20mg\/kg\/day, whereas more adverse events occurred in the 40mg\/kg\/day than in the placebo group. The 60mg\/kg\/day dose was discontinued due to worsening of ataxia in 2 patients. One patient on deferiprone 20mg\/kg\/day experienced reversible neutropenia, but none developed agranulocytosis. Deferiprone\u2010treated patients receiving 20 or 40mg\/kg\/day showed a decline in the left ventricular mass index, compared to an increase in the placebo\u2010treated patients. Patients receiving 20mg\/kg\/day of deferiprone had no significant change in FARS, similar to the placebo\u2010treated patients, whereas those receiving 40mg\/kg\/day had worsening in FARS and ICARS scores. The lack of deterioration in the placebo arm impaired the ability to detect any potential protective effect of deferiprone. However, subgroup analyses in patients with less severe disease suggested a benefit of deferiprone 20mg\/kg\/day on ICARS, FARS, kinetic function, and 9HPT.<\/jats:p><\/jats:sec><jats:sec><jats:title>Interpretation<\/jats:title><jats:p>This study demonstrated an acceptable safety profile of deferiprone at 20mg\/kg\/day for the treatment of patients with FRDA. Subgroup analyses raise the possibility that, in patients with less severe disease, deferiprone 20mg\/kg\/day may reduce disease progression, whereas higher doses appear to worsen ataxia. Ann Neurol 2014;76:509\u2013521<\/jats:p><\/jats:sec>","DOI":"10.1002\/ana.24248","type":"journal-article","created":{"date-parts":[[2014,8,11]],"date-time":"2014-08-11T15:57:27Z","timestamp":1407772647000},"page":"509-521","source":"Crossref","is-referenced-by-count":137,"title":["Deferiprone in <scp>F<\/scp>riedreich ataxia: A 6\u2010Month randomized controlled trial"],"prefix":"10.1002","volume":"76","author":[{"given":"Massimo","family":"Pandolfo","sequence":"first","affiliation":[{"name":"Department of Neurology, Erasme Hospital Universit\u00e9 Libre de Bruxelles  Brussels Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Arpa","sequence":"additional","affiliation":[{"name":"Neurology Service La Paz University Hospital Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin B.","family":"Delatycki","sequence":"additional","affiliation":[{"name":"Bruce Lefroy Centre for Genetic Health Research Murdoch Children's Research Institute Parkville Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim Hanh","family":"Le Quan Sang","sequence":"additional","affiliation":[{"name":"Necker\u2013Sick Children Hospital Center Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Mariotti","sequence":"additional","affiliation":[{"name":"Unit of Genetics of Neurodegenerative and Metabolic Disease Carlo Besta Neurological Institute, Institute of Hospitalization and Scientific Care Foundation Milan Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnold","family":"Munnich","sequence":"additional","affiliation":[{"name":"Necker\u2013Sick Children Hospital Center Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Sanz\u2010Gallego","sequence":"additional","affiliation":[{"name":"Neurology Service La Paz University Hospital Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geneieve","family":"Tai","sequence":"additional","affiliation":[{"name":"Bruce Lefroy Centre for Genetic Health Research Murdoch Children's Research Institute Parkville Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Tarnopolsky","sequence":"additional","affiliation":[{"name":"Division of Neurology, Department of Medicine McMaster University Medical Centre Hamilton Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Taroni","sequence":"additional","affiliation":[{"name":"Unit of Genetics of Neurodegenerative and Metabolic Disease Carlo Besta Neurological Institute, Institute of Hospitalization and Scientific Care Foundation Milan Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Spino","sequence":"additional","affiliation":[{"name":"ApoPharma Toronto Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Tricta","sequence":"additional","affiliation":[{"name":"ApoPharma Toronto Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,8,30]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-009-1002-3"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.12215"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.12317"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.12217"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2011.05.023"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.12216"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.271.5254.1423"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature01596"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio815"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.12254"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/6.11.1771"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1021\/bi1013062"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1021\/ja308736e"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.009019"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddm163"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng1097-215"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1096\/fj.09-143222"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2005.04.040"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-211-45295-0_22"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-07-102335"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-06-161919"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-12-065433"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000156802.15466.79"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000218155.46739.90"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-510X(96)00231-6"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.a3006"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1177\/0883073812448462"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(07)70220-X"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2010.168"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1177\/0883073812453872"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/aws309"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12311-010-0212-7"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/ane.12141"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2377-8-20"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddn127"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0055940"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1517\/21678707.2013.771578"}],"container-title":["Annals of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fana.24248","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ana.24248","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T20:05:29Z","timestamp":1696622729000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ana.24248"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,30]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["10.1002\/ana.24248"],"URL":"https:\/\/doi.org\/10.1002\/ana.24248","archive":["Portico"],"relation":{},"ISSN":["0364-5134","1531-8249"],"issn-type":[{"value":"0364-5134","type":"print"},{"value":"1531-8249","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,30]]}}}